Genetic Variants of Arachidonate 5-Lipoxygenase–Activating Protein, and Risk of Incident Myocardial Infarction and Ischemic Stroke

2006102 citationsJournal Article

Authors

Robert Y.L. Zee · GeneTrace Systems (United States)

Suzanne Cheng · GeneTrace Systems (United States)

Hillary H. Hegener · GeneTrace Systems (United States)

Henry A. Erlich · GeneTrace Systems (United States)

Paul M. Ridker · GeneTrace Systems (United States)

Abstract

We found no evidence for an association of the specific Icelandic ALOX5P gene variants/at-risk haplotypes tested with risk of incident MI nor ischemic stroke in this prospective, non-Icelandic study.

Topics & Keywords

Nitric Oxide and Endothelin Effects Renin-Angiotensin System Studies Heart Failure Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Stroke

Volume 37, Issue 8, pp. 2007-2011

DOI: 10.1161/01.str.0000229905.25080.01

Field-Weighted Citation Impact: 7.06